Aytu BioPharma Announces Patent Term Extension for EXXUA(TM)
DENVER, CO / ACCESS Newswire / October 28, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical...
DENVER, CO / ACCESS Newswire / October 28, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical...
Independent research shows that the self-paced “Still Tinnitus” course can help reduce tinnitus symptoms and improve quality of life for...
Key Highlights:Pivot continues to progress toward CE Mark certification in 2026Stage 1 ISO Audit completed with Stage 2 planned for...
The industry-leading 503B outsourcing facility grows its footprint to 49 states, offering expanded healthcare resources with a spotlight on MississippiORLANDO,...
SAN JOSE, CALIFORNIA / ACCESS Newswire / October 28, 2025 / VSee Health, Inc. (Nasdaq:VSEE) (the "Company"), announced it has...
NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- CB Insights named Sevaro Health to its seventh annual Digital Health 50,...
Accreditation for its lifestyle and disease management interventions complements Sharecare's existing three-year NCQA accreditations for Population Health Program and Case...
ATLANTA, GEORGIA / ACCESS Newswire / October 28, 2025 / Florence Healthcare, the leading clinical trial platform connecting pharmaceutical sponsors...
ADELAIDE, Australia, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Avance Clinical, the award-winning Australian led, global CRO built exclusively to service...
ZIONSVILLE, IN / ACCESS Newswire / October 28, 2025 / WellBridge Surgical ("WellBridge") is delighted to announce two major milestones...
Seasoned Pharmaceutical leader bringing over 24 years of experience in clinical development across autoimmune, metabolic, cardiovascular, and gastrointestinal indications Company...
Chantilly and Tysons Corner sites expand access to early intervention services for young children with autismSILVER SPRING, Md., Oct. 28,...
Achieved key operational milestones establishing manufacturing capabilities to supply more than 2x the products required to achieve 2026 revenue targets...
FORT LAUDERDALE, FL / ACCESS Newswire / October 28, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical...
Q3 2025 net product revenue for ZORYVE® (roflumilast) was $99.2 million, a 122% increase compared to Q3 of 2024,...
This Acquisition Advances PHCG’s Entry Into AI-Driven Video, 3D Data Visualization, and Immersive Media Technologies Powering Multiple IndustriesDENVER, Oct. 28,...
NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement...
“MEDIROM is a location partner for the World Network, co-founded by Sam Altman and Alex Blania, to promote domestic adoption...
Global functional gummy supplements market projected to surpass $50 billion by 2030 - CBDL expands into two of the fastest-growing...
Recruitment of Three Additional Pediatric Patients in Austria and Ireland Achieves Investigator Study TargetCurrent Pediatric Patient in Ongoing Study Has...